Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Treatment of Severe Acute Respiratory Distress Syndrome With Allogeneic Bone Marrow-derived Mesenchymal Stromal Cells

NCT02215811 is registered in ClinicalTrials.gov with Karolinska University Hospital as lead sponsor.

NCT NCT02215811
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02215811 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Treatment of Severe Acute Respiratory Distress Syndrome With Allogeneic Bone Marrow-derived Mesenchymal Stromal Cells
Lead sponsor
Karolinska University Hospital
Phase
Phase 1
Overall status
Unknown status
Start date
March 31, 2014
Completion date
Not reported
Enrollment
10 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

acute respiratory distress syndrome, adult